Summary: This week we delve into the world of general pediatric cardiology as well as EP as we review a recent work from the Boston Children's group on management of SVT in the ED. How often are patients admitted to the hospital after conversion of SVT? How frequently are 2nd agents required to terminate SVT beyond adenosine? Why do differences exist in the management of these patients between hospital systems? Boston Children's Hospital cardiology fellow, Dr. Robert Przybylski shares his insights into this week's important and practical work. doi: 10.1007/s00246-020-02515-8
